HARARE, Zimbabwe – Contrary to earlier assertions by the Zimbabwean government, new information suggests that the rejected US$367 million health aid agreement did not contain clauses related to critical minerals or the misuse of sensitive health data.
The proposed five-year deal, spearheaded by the United States, was designed to bolster Zimbabwe’s priority health programs, including HIV/AIDS prevention and treatment, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
The Bone of Contention
Previously, government spokespersons indicated that the United States was demanding access to biological samples for research and commercial gain without a fair benefit-sharing model for future vaccines. Further concerns were raised regarding potential “hidden” clauses in the Memorandum of Understanding (MoU) that might have granted the U.S. access to Zimbabwe’s critical mineral reserves.
However, a U.S. official clarified this week that the proposed agreement focused exclusively on health cooperation. The official stated there were no provisions—explicit or implicit—linking the aid to minerals.
“The Government of Zimbabwe engaged with us at the technical level for weeks, and our teams made much progress on negotiations of this legally non-binding MoU,” the official noted. “There were many tracked changes in this document, and no policy or political concerns were relayed to us. The government then notified us it was ceasing negotiations without stating why.”
Data Sharing and International Protocols
Addressing fears over data sovereignty, the U.S. official emphasized that the MoU followed international best practices, stipulating the collection of only anonymous, aggregated health data.
This data is reportedly the same type shared since the inception of PEPFAR in 2006, used primarily to measure program success and coordinate responses to disease outbreaks. The ultimate goal, according to the U.S., was to facilitate a gradual transition of healthcare responsibility back to the Zimbabwean government.
The Impact of Withdrawal
The collapse of the deal has forced the U.S. to begin scaling back health funding. A statement from the U.S. Embassy last month highlighted that the collaboration would have benefited over 1.2 million Zimbabweans currently receiving life-saving HIV treatment.
U.S. Ambassador Pamela Tremont indicated that the embassy must now undertake the “difficult and regrettable task” of winding down health assistance.
| Key Stats: The Rejected Deal | Details |
| Total Value | US$367 Million |
| Duration | 5 Years |
| Model | Co-funding for sustainability |
| Regional Context | 16 other African nations signed similar MoUs |
| Total Regional Funding | US$18.3 Billion |
A Legacy at Risk?
The proposed MoU was set to be the largest single health investment in Zimbabwe’s history. Since 2006, the U.S. has provided over US$1.9 billion in health assistance, a factor widely credited with helping Zimbabwe achieve the UNAIDS 95-95-95 goals.
This funding has seen Zimbabwe’s life expectancy rise from 58 years in 1995 to approximately 66 years in 2024. Furthermore, the number of AIDS-related orphans has plummeted from over one million in the early 2000s to roughly 400,000 in 2023.
As negotiations remain stalled, the future of these gains now rests on the government’s ability to fill the funding gap left by the withdrawal of its largest bilateral aid contributor.
For comments, Feedback and Opinions do get in touch with our editor on WhatsApp: +44 7949 297606 or Email: editor@thezimbabwetimes.co.zw.
